| | ENG

For Investigators Only

CN102c: Lithium±UCBMC Trial for Acute/Subacute SCI
This trial is to assess the safety and efficacy of lithium, umbilical cord blood mononuclear cell transplant and their combination in the treatment of acute/subacute spinal cord injury. The trial enrolled 16 patients who had traumatic spinal cord injury in 4 weeks before the treatment.  The study closed at the end of 2013. 

Participating Site: Chengdu Army Command Kunming General Hospital, Kunming.

Principal Investigator: Dr. Hui ZHU

No. of Subjects Enrolled: 16 

Sponsorship: 2010 Yunnan Social Development and Technology Program, 2010 Military Clinical High-Tech Program, Hong Kong Spinal Cord Injury Fund and Stemcyte Inc.

For more information, please refer to:

Clinicaltrials.gov: NCT01471613

What should I do if I would like to participate in the trials of ChinaSCINet?
To learn as much as possible about the clinical trial and then contact the investigator directly. You may also leave your basic information and contact here (Submit a Form). The investigators may retrieve the data and contact you if they think you might be suitable candidate for the trial.

To read more:

About Clinical Research

About Lithium and Cord Blood Cells

Copyright © 2020. CHINASCINET
About Us | SCI Info | Studies | Events | ISCITT | Contact